Latest Insider Transactions at Blueprint Medicines Corp (BPMC)
This section provides a real-time view of insider transactions for Blueprint Medicines Corp (BPMC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Blueprint Medicines Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Blueprint Medicines Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 03
2024
|
Fouad Namouni PRESIDENT, R & D |
SELL
Open market or private sale
|
Direct |
3,633
-5.0%
|
$323,337
$89.32 P/Share
|
|
Sep 09
2024
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
19,702
-5.72%
|
$1,674,670
$85.49 P/Share
|
|
Sep 09
2024
|
Jeffrey W. Albers |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+5.34%
|
$360,000
$36.05 P/Share
|
|
Aug 15
2024
|
Michael Landsittel CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,409
-6.16%
|
$418,855
$95.23 P/Share
|
|
Aug 05
2024
|
Philina Lee CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
41,913
-54.69%
|
$3,897,909
$93.19 P/Share
|
|
Aug 05
2024
|
Philina Lee CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
41,913
+9.21%
|
$2,472,867
$59.11 P/Share
|
|
Jul 05
2024
|
Debra Durso Bumpus CHIEF PEOPLE OFFICER |
SELL
Open market or private sale
|
Direct |
3,850
-8.09%
|
$427,350
$111.2 P/Share
|
|
Jul 05
2024
|
Debra Durso Bumpus CHIEF PEOPLE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,850
+7.48%
|
$207,900
$54.13 P/Share
|
|
Jul 03
2024
|
Debra Durso Bumpus CHIEF PEOPLE OFFICER |
SELL
Open market or private sale
|
Direct |
8,817
-16.77%
|
$978,687
$111.29 P/Share
|
|
Jul 03
2024
|
Debra Durso Bumpus CHIEF PEOPLE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,817
+14.36%
|
$476,118
$54.13 P/Share
|
|
Jul 01
2024
|
Christina Rossi CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
9,625
+11.52%
|
-
|
|
Jul 01
2024
|
Percy H. Carter CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
7,500
+13.18%
|
-
|
|
Jun 28
2024
|
Debra Durso Bumpus CHIEF PEOPLE OFFICER |
SELL
Open market or private sale
|
Direct |
333
-0.76%
|
$36,963
$111.15 P/Share
|
|
Jun 28
2024
|
Debra Durso Bumpus CHIEF PEOPLE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
333
+0.75%
|
$17,982
$54.13 P/Share
|
|
Jun 21
2024
|
Debra Durso Bumpus CHIEF PEOPLE OFFICER |
SELL
Open market or private sale
|
Direct |
74,034
-16.48%
|
$7,699,536
$104.09 P/Share
|
|
Jun 21
2024
|
Debra Durso Bumpus CHIEF PEOPLE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
60,482
+13.81%
|
$1,874,942
$31.55 P/Share
|
|
Jun 12
2024
|
Jeffrey W. Albers |
BUY
Grant, award, or other acquisition
|
Direct |
2,242
+1.32%
|
-
|
|
Jun 12
2024
|
Nicholas Lydon |
BUY
Grant, award, or other acquisition
|
Direct |
2,242
+3.72%
|
-
|
|
Jun 12
2024
|
Lynn Seely |
BUY
Grant, award, or other acquisition
|
Direct |
2,242
+14.47%
|
-
|
|
Jun 12
2024
|
John Tsai |
BUY
Grant, award, or other acquisition
|
Direct |
2,242
+20.41%
|
-
|
|
Jun 12
2024
|
Lonnel Coats |
BUY
Grant, award, or other acquisition
|
Direct |
2,242
+14.47%
|
-
|
|
Jun 12
2024
|
Daniella Beckman |
BUY
Grant, award, or other acquisition
|
Direct |
2,242
+17.14%
|
-
|
|
Jun 12
2024
|
Habib J Dable |
BUY
Grant, award, or other acquisition
|
Direct |
2,242
+20.41%
|
-
|
|
Jun 12
2024
|
Alexis Borisy |
BUY
Grant, award, or other acquisition
|
Direct |
2,242
+2.93%
|
-
|
|
Jun 12
2024
|
Mark Alan Goldberg |
BUY
Grant, award, or other acquisition
|
Direct |
2,242
+10.94%
|
-
|
|
Jun 05
2024
|
Percy H. Carter CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
4,000
-8.72%
|
$420,000
$105.13 P/Share
|
|
Jun 04
2024
|
L. Becker Hewes CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,424
-7.59%
|
$252,096
$104.91 P/Share
|
|
Jun 03
2024
|
Percy H. Carter CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
2,436
-5.04%
|
$258,216
$106.43 P/Share
|
|
Jun 03
2024
|
L. Becker Hewes CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,922
-6.91%
|
$521,732
$106.43 P/Share
|
|
May 31
2024
|
L. Becker Hewes CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
34,108
-14.3%
|
$3,615,448
$106.25 P/Share
|
|
May 31
2024
|
L. Becker Hewes CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
24,687
+11.51%
|
$1,382,472
$56.9 P/Share
|
|
May 15
2024
|
Michael Landsittel CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,850
-2.58%
|
$408,100
$106.86 P/Share
|
|
May 15
2024
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
5,856
-15.24%
|
$620,736
$106.89 P/Share
|
|
May 15
2024
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,856
+12.47%
|
$228,384
$39.6 P/Share
|
|
May 08
2024
|
Michael Landsittel CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
28,181
+14.36%
|
$140,905
$5.34 P/Share
|
|
May 02
2024
|
Michael Landsittel CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-17.46%
|
$1,050,000
$105.0 P/Share
|
|
May 02
2024
|
Michael Landsittel CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+14.86%
|
$360,000
$36.05 P/Share
|
|
May 02
2024
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
1,834
-10.95%
|
$188,902
$103.88 P/Share
|
|
May 02
2024
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,834
+9.87%
|
$99,036
$54.13 P/Share
|
|
Mar 28
2024
|
Michael Landsittel CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,000
-9.56%
|
$475,000
$95.0 P/Share
|
|
Mar 28
2024
|
Michael Landsittel CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+8.73%
|
$180,000
$36.05 P/Share
|
|
Mar 20
2024
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
25,073
-2.62%
|
$2,181,351
$87.33 P/Share
|
|
Mar 20
2024
|
Jeffrey W. Albers |
BUY
Exercise of conversion of derivative security
|
Direct |
25,073
+6.02%
|
$200,584
$8.44 P/Share
|
|
Mar 15
2024
|
Michael Landsittel CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
13,734
-4.14%
|
$1,208,592
$88.06 P/Share
|
|
Mar 15
2024
|
Michael Landsittel CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+7.57%
|
$180,000
$36.05 P/Share
|
|
Mar 15
2024
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
4,549
-8.36%
|
$400,312
$88.19 P/Share
|
|
Mar 15
2024
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,600
+4.11%
|
$24,000
$15.01 P/Share
|
|
Mar 13
2024
|
Philina Lee CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
8,023
-9.74%
|
$722,070
$90.22 P/Share
|
|
Mar 13
2024
|
Philina Lee CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,747
+2.01%
|
$19,217
$11.91 P/Share
|
|
Mar 07
2024
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
11,033
-6.27%
|
$992,970
$90.69 P/Share
|